Iconovo
1.12 SEK
-5.88 %
Less than 1K followers
ICO
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-5.88 %
-1.75 %
-1.75 %
-10.76 %
-49.32 %
-63.41 %
-97.06 %
-97.85 %
-96.56 %
Iconovo operates in the medical technology sector. The company develops inhalers for medical use. The company's products are used in the treatment of asthma and coal, where the inhalers consist of powder-based medicine. The products are licensed and sold under various brands. In addition to product development, there is expertise in pharmaceutical formulation. The company was founded in 2013 and has its headquarters in Lund.
Read moreMarket cap
107.71M SEK
Turnover
87.7K SEK
Revenue
1.11M
EBIT %
-3,883.78 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
24/4
2026
Interim report Q1'26
28/5
2026
General meeting '26
20/8
2026
Interim report Q2'26
All
Press releases
3rd party
ShowingAll content types
Iconovo’s rights issue is registered – conversion of BTA into shares
Iconovo offentliggör slutligt utfall i företrädesemissionen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools